From: Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer screening study in Mozambique
WLWH
(n = 1,621)
HIV negative (n = 1,167)
Total
(n = 2,788)
p-value
HPV16
297 (18.3%)
181 (15.3%)
478 (17.0%)
0.05
HPV18/45
424 (26.1%)
264 (22.5%)
686 (24.6%)
0.03
Other HR-HPV**
1253 (77.3%)
911 (77.4%)
2164 (77.6%)
0.60